The growing genetic and functional diversity of extended spectrum beta‐lactamases

S ur Rahman, T Ali, I Ali, NA Khan… - BioMed research …, 2018 - Wiley Online Library
The β‐lactams—a large class of diverse compounds—due to their excellent safety profile
and broad antimicrobial spectrum are considered to be the most widely used therapeutic …

The changing epidemiology of resistance

PM Hawkey, AM Jones - Journal of antimicrobial chemotherapy, 2009 - academic.oup.com
Antibiotic resistance is now a linked global problem. Dispersion of successful clones of
multidrug resistant (MDR) bacteria is common, often via the movement of people. Local …

[HTML][HTML] Antibiotic resistance and extended spectrum beta-lactamases: Types, epidemiology and treatment

S Shaikh, J Fatima, S Shakil, SMD Rizvi… - Saudi journal of …, 2015 - Elsevier
Antibiotic resistance is a problem of deep scientific concern both in hospital and community
settings. Rapid detection in clinical laboratories is essential for the judicious recognition of …

[HTML][HTML] Molecular characterization of Extended-spectrum β lactamase- producing E. coli recovered from community-acquired urinary tract infections in Upper Egypt

NA Hassuna, AS Khairalla, EM Farahat, AM Hammad… - Scientific reports, 2020 - nature.com
Abstract Treatment of community urinary tract infections (UTIs) caused by extended-
spectrum β lactamase (ESBL)-producing Escherichia coli (E. coli) is more expensive than …

[HTML][HTML] High prevalence of extended-spectrum ß-lactamase producing enterobacteriaceae among clinical isolates in Burkina Faso

AS Ouedraogo, M Sanou, A Kissou, S Sanou… - BMC infectious …, 2016 - Springer
Background Nothing is known about the epidemiology and resistance mechanisms of
extended-spectrum ß-lactamase-producing Enterobacteriaceae (ESBL-PE) in Burkina Faso …

Landscape of multidrug-resistant gram-negative infections in Egypt: survey and literature review

A El-Kholy, HA El-Mahallawy… - Infection and drug …, 2021 - Taylor & Francis
Purpose This article is the first to review published reports on the prevalence of multidrug-
resistant (MDR) gram-negative infections in Egypt and gain insights into antimicrobial …

Investigation of Antibiotic Resistance and Biofilm Formation in Clinical Isolates of Klebsiella pneumoniae

K Karimi, O Zarei, P Sedighi, M Taheri… - International Journal …, 2021 - Wiley Online Library
Aim. Klebsiella pneumoniae (K. pneumoniae) is an encapsulated Gram‐negative bacterium
that can lead to 14–20% of nosocomial infections. The ability of biofilm formation in this …

Prevalence and molecular characterization of extended-spectrum β-lactamase-producing Klebsiella pneumoniae in Riyadh, Saudi Arabia

MHM Al-Agamy, AM Shibl, AF Tawfik - Annals of Saudi medicine, 2009 - annsaudimed.net
BACKGROUND AND OBJECTIVES: Reports on extended-spectrum β-lactamases (ESBL)
production by Enterobacteriaceae, and especially in Klebsiella pneumoniae, are few in …

Extended-spectrum beta-lactamase-producing Escherichia coli in patients with travellers' diarrhoea

J Tham, I Odenholt, M Walder, A Brolund… - … journal of infectious …, 2010 - Taylor & Francis
The identification of patients carrying extended-spectrum beta-lactamase (ESBL)-producing
bacteria is important, since these patients are at risk of receiving inappropriate empirical …

CTX-M-15-Producing Escherichia coli Clinical Isolates in Cairo (Egypt), Including Isolates of Clonal Complex ST10 and Clones ST131, ST73, and ST405 in Both …

N Fam, V Leflon-Guibout, S Fouad… - Microbial drug …, 2011 - liebertpub.com
In Egypt, little is known about the genetic background of Escherichia coli isolates harboring
extended-spectrum β-lactamase (ESBL). Five hundred twenty Enterobacteriaceae were …